Mark Ballantyne

Associate

I love the challenges of working with technology and life sciences companies as they evolve from startups to public companies.

+1 703 456 8084
mballantyne@cooley.com

Mark Ballantyne focuses his practice on representing IPO ready and publicly traded life sciences and technology companies, as well as underwriters.

Download full bio

Experience

  • OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals 

  • Verrica Pharmaceuticals – $86 Million IPO 

  • Translate Bio – $122 Million IPO 

  • 2U $119 Million Initial Public Offering 

  • T2 Biosystems IPO 

  • View all

Education

  • University of Richmond School of Law
    JD, magna cum laude, Order of the Coif, McNeill Law Society, 2012

  • Wake Forest University
    BA, 2008


Admissions & Credentials

Virginia

Contact

+1 703 456 8084 office
+1 703 456 8100 fax
mballantyne@cooley.com

Reston Town Center
11951 Freedom Drive
14th Floor
Reston, VA 20190-5640